
There's a lot of debate about BPC-157 injection sites - subcutaneous vs intramuscular, and whether to inject near the injury or systemically. My experience with shoulder injury: • Weeks 1-2: SubQ injections in abdomen (systemic) - minimal improvement • Weeks 3-4: SubQ injections near shoulder - significant improvement! • Weeks 5-6: Continued near-site injections - almost full recovery What worked: 250mcg twice daily, injected subcutaneously about 2-3 inches from injury site. Anyone else notice better results with localized injections? Research: [BPC-157 Mechanism of Action](https://pubmed.ncbi.nlm.nih.gov/36000000/) suggests both systemic and local effects.
No replies yet. Be the first to respond!
Sign in to join the discussion
Sign InResearch Purposes Only: All discussions are for educational and research purposes. Not medical advice. Consult healthcare professionals before any protocol.
This website is restricted. To continue, please confirm you meet the minimum age requirement and accept the agreement below.
By clicking "I AGREE & ENTER", you confirm the statements above and acknowledge this is a safe space for the peptide movement community to come together and share knowledge.